Drugs / GIB-7
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07363057 | Jan → May 2026 overdue | — | GI Innovation, Inc. | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GIB-7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07363057 ↗ |
| Modality | Other / unclassified | “GIB-7: synbiotic formula” NCT07363057 ↗ |
| Route | Oral | “GIB-7: synbiotic formula, oral administration” NCT07363057 ↗ |